-
Something wrong with this record ?
Molecular-Level Control of Ciclopirox Olamine Release from Poly(ethylene oxide)-Based Mucoadhesive Buccal Films: Exploration of Structure-Property Relationships with Solid-State NMR
M. Urbanova, M. Gajdosova, M. Steinhart, D. Vetchy, J. Brus,
Language English Country United States
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT14477
MZ0
CEP Register
- MeSH
- Adhesives chemistry metabolism MeSH
- Biological Availability MeSH
- Chemistry, Pharmaceutical methods MeSH
- Ethylene Oxide chemistry MeSH
- Crystallization methods MeSH
- Magnetic Resonance Spectroscopy methods MeSH
- Nanoparticles chemistry MeSH
- Oral Mucosal Absorption physiology MeSH
- Polyethylene Glycols chemistry metabolism MeSH
- Polymers chemistry MeSH
- Pyridones chemistry MeSH
- Solubility MeSH
- Mouth Mucosa metabolism MeSH
- Drug Liberation physiology MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
Mucoadhesive buccal films (MBFs) provide an innovative way to facilitate the efficient site-specific delivery of active compounds while simultaneously separating the lesions from the environment of the oral cavity. The structural diversity of these complex multicomponent and mostly multiphase systems as well as an experimental strategy for their structural characterization at molecular scale with atomic resolution were demonstrated using MBFs of ciclopirox olamine (CPX) in a poly(ethylene oxide) (PEO) matrix as a case study. A detailed description of each component of the CPX/PEO films was followed by an analysis of the relationships between each component and the physicochemical properties of the MBFs. Two distinct MBFs were identified by solid-state NMR spectroscopy: (i) at low API (active pharmaceutical ingredient) loading, a nanoheterogeneous solid solution of CPX molecularly dispersed in an amorphous PEO matrix was created; and (ii) at high API loading, a pseudoco-crystalline system containing CPX-2-aminoethanol nanocrystals incorporated into the interlamellar space of a crystalline PEO matrix was revealed. These structural differences were found to be closely related to the mechanical and physicochemical properties of the prepared MBFs. At low API loading, the polymer chains of PEO provided sufficient quantities of binding sites to stabilize the CPX that was molecularly dispersed in the highly amorphous semiflexible polymer matrix. Consequently, the resulting MBFs were soft, with low tensile strength, plasticity, and swelling index, supporting rapid drug release. At high CPX content, however, the active compounds and the polymer chains simultaneously cocrystallized, leaving the CPX to form nanocrystals grown directly inside the spherulites of PEO. Interfacial polymer-drug interactions were thus responsible not only for the considerably enhanced plasticity of the system but also for the exclusive crystallization of CPX in the thermodynamically most stable polymorphic form, Form I, which exhibited reduced dissolution kinetics. The bioavailability of CPX olamine formulated as PEO-based MBFs can thus be effectively controlled by inducing the complete dispersion and/or microsegregation and nanocrystallization of CPX olamine in the polymer matrix. Solid-state NMR spectroscopy is an efficient tool for exploring structure-property relationships in these complex pharmaceutical solids.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc18017320
- 003
- CZ-PrNML
- 005
- 20190516145627.0
- 007
- ta
- 008
- 180515s2016 xxu f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1021/acs.molpharmaceut.6b00035 $2 doi
- 035 __
- $a (PubMed)27019088
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Urbanova, Martina $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic , Heyrovsky sq. 2, 162 06 Prague 6, Czech Republic.
- 245 10
- $a Molecular-Level Control of Ciclopirox Olamine Release from Poly(ethylene oxide)-Based Mucoadhesive Buccal Films: Exploration of Structure-Property Relationships with Solid-State NMR / $c M. Urbanova, M. Gajdosova, M. Steinhart, D. Vetchy, J. Brus,
- 520 9_
- $a Mucoadhesive buccal films (MBFs) provide an innovative way to facilitate the efficient site-specific delivery of active compounds while simultaneously separating the lesions from the environment of the oral cavity. The structural diversity of these complex multicomponent and mostly multiphase systems as well as an experimental strategy for their structural characterization at molecular scale with atomic resolution were demonstrated using MBFs of ciclopirox olamine (CPX) in a poly(ethylene oxide) (PEO) matrix as a case study. A detailed description of each component of the CPX/PEO films was followed by an analysis of the relationships between each component and the physicochemical properties of the MBFs. Two distinct MBFs were identified by solid-state NMR spectroscopy: (i) at low API (active pharmaceutical ingredient) loading, a nanoheterogeneous solid solution of CPX molecularly dispersed in an amorphous PEO matrix was created; and (ii) at high API loading, a pseudoco-crystalline system containing CPX-2-aminoethanol nanocrystals incorporated into the interlamellar space of a crystalline PEO matrix was revealed. These structural differences were found to be closely related to the mechanical and physicochemical properties of the prepared MBFs. At low API loading, the polymer chains of PEO provided sufficient quantities of binding sites to stabilize the CPX that was molecularly dispersed in the highly amorphous semiflexible polymer matrix. Consequently, the resulting MBFs were soft, with low tensile strength, plasticity, and swelling index, supporting rapid drug release. At high CPX content, however, the active compounds and the polymer chains simultaneously cocrystallized, leaving the CPX to form nanocrystals grown directly inside the spherulites of PEO. Interfacial polymer-drug interactions were thus responsible not only for the considerably enhanced plasticity of the system but also for the exclusive crystallization of CPX in the thermodynamically most stable polymorphic form, Form I, which exhibited reduced dissolution kinetics. The bioavailability of CPX olamine formulated as PEO-based MBFs can thus be effectively controlled by inducing the complete dispersion and/or microsegregation and nanocrystallization of CPX olamine in the polymer matrix. Solid-state NMR spectroscopy is an efficient tool for exploring structure-property relationships in these complex pharmaceutical solids.
- 650 _2
- $a adheziva $x chemie $x metabolismus $7 D000269
- 650 _2
- $a biologická dostupnost $7 D001682
- 650 _2
- $a chemie farmaceutická $x metody $7 D002626
- 650 _2
- $a krystalizace $x metody $7 D003460
- 650 _2
- $a uvolňování léčiv $x fyziologie $7 D065546
- 650 _2
- $a ethylenoxid $x chemie $7 D005027
- 650 _2
- $a magnetická rezonanční spektroskopie $x metody $7 D009682
- 650 _2
- $a ústní sliznice $x metabolismus $7 D009061
- 650 _2
- $a nanočástice $x chemie $7 D053758
- 650 _2
- $a orální absorpce $x fyziologie $7 D065568
- 650 _2
- $a polyethylenglykoly $x chemie $x metabolismus $7 D011092
- 650 _2
- $a polymery $x chemie $7 D011108
- 650 _2
- $a pyridony $x chemie $7 D011728
- 650 _2
- $a rozpustnost $7 D012995
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Gajdošová, Markéta $u Veterinary and Pharmaceutical University , Faculty of Pharmacy, Department of Pharmaceutics, Palacky Street 1946/1, 612 42 Brno, Czech Republic. $7 ola20191054731
- 700 1_
- $a Steinhart, Miloš, $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic , Heyrovsky sq. 2, 162 06 Prague 6, Czech Republic. $d 1955- $7 ola2002159208
- 700 1_
- $a Vetchý, David, $u Veterinary and Pharmaceutical University , Faculty of Pharmacy, Department of Pharmaceutics, Palacky Street 1946/1, 612 42 Brno, Czech Republic. $d 1972- $7 mzk2006368163
- 700 1_
- $a Brus, Jiří, $u Institute of Macromolecular Chemistry, Academy of Sciences of the Czech Republic , Heyrovsky sq. 2, 162 06 Prague 6, Czech Republic. $d 1970- $7 jo2011640489
- 773 0_
- $w MED00008279 $t Molecular pharmaceutics $x 1543-8392 $g Roč. 13, č. 5 (2016), s. 1551-1563
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/27019088 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20180515 $b ABA008
- 991 __
- $a 20190516145734 $b ABA008
- 999 __
- $a ok $b bmc $g 1300944 $s 1014160
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2016 $b 13 $c 5 $d 1551-1563 $e 20160405 $i 1543-8392 $m Molecular pharmaceutics $n Mol Pharm $x MED00008279
- GRA __
- $a NT14477 $p MZ0
- LZP __
- $a Pubmed-20180515